A recently filed lawsuit holds a Malibu rehab facility responsible for Emily Willis becoming ‘permanently disabled’ after she ...

The Cambridge, Mass., biotechnology company on Thursday said it received a notice of allowance from the U.S. Patent and Trademark Office regarding the drug candidate, ED-003, which is intended to ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

Medical terminology has often confused some of the everyday health conditions related to a body part. Several terms, notably syndrome, disorder, and disease, are habitually misapplied. With apparent ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Glutamatergic medications are linked to significant symptom improvement in obsessive-compulsive and related disorders, a new ...

For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

A study found that older adults with anxiety may have an increased risk of developing dementia—but this risk decreased once ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...